The UK government’s £500m Sovereign AI Fund is in talks to invest in London-based drug discovery startup Potential Sciences, according to reports. Source: Sifted · Summarized by HeadlinesBriefing Related articlesThe UK’s £500m Sovereign AI Unit just struck deals with these 7 startupsLovable backer Creandum raises $750m for largest-ever fund to back AI boomUK firms ‘should be worried’ about Anthropic’s latest AI model, minister saysNorway's Investinor out raising new LP fund amid European push to fund scaleupsExclusive: British Business Bank puts £180m into six AI funds, including Evantic and EFMore from SiftedWhat Sequoia’s London exit means for EuropeEuropean startups are using rollup strategies for defence. Some VCs are scepticalThe 12 startups most in demand from Onstage's W26 cohortInside the race to build European hardware without ChinaEarly Revolut employees emerge from stealth with AI wealthtech HaidoLatest in Private MarketsThe Week’s 10 Biggest Funding Rounds: AI, Defense And Space Tech Lead For Large Rounds · Crunchbase NewsMSREI’s Tim Breitenstein: Investors need ‘ammunition’ for more real estate allocation · Real Estate InvestorFund Friday: Top fundraising news in private equity · PE InsightsAres adds equity to its lending role as Equinox lines up $1bn for growth · PE InsightsHealthcare & Life Sciences Private Equity Deal Tracker: Webster Equity to Acquire Lifecore · Healthcare InvestorRelated briefingsMarkets 24-Hour BriefingMarkets 8-Hour BriefingHomePrivate MarketsUK Sovereign AI Fund in £500m Drug Discovery TalksSectionsHomePublic MarketsPrivate MarketsTech & GamesMobileDeveloperF1Sports